Testing effectiveness (Phase 2)Ended earlyNCT01064037
What this trial is testing
A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Who this might be right for
Heart FailureHeart Decompensation
Bayer 62